$29.80
-0.59-1.94%
마지막 업데이트: Oct 13, 4:00 PM
Benzinga
Benzinga
Benzinga
수요일, 10월 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Hemab Therapeutics Hldgs (COAG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.78 | — |
| Actual | $-0.80 | $-23.98 |
| Surprise | -2.56% | — |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.51 | $-0.57 | $-0.49 | $-0.65 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.80 | $-0.78 | -2.56 % |